Annual Book Value
$36.96 M
-$14.87 M-28.68%
31 December 2023
Summary:
Theriva Biologics annual book value is currently $36.96 million, with the most recent change of -$14.87 million (-28.68%) on 31 December 2023. During the last 3 years, it has risen by +$44.21 million (+610.26%). TOVX annual book value is now -43.49% below its all-time high of $65.41 million, reached on 31 December 2021.TOVX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$24.64 M
-$1.26 M-4.88%
01 September 2024
Summary:
Theriva Biologics quarterly book value is currently $24.64 million, with the most recent change of -$1.26 million (-4.88%) on 01 September 2024. Over the past year, it has dropped by -$16.52 million (-40.13%). TOVX quarterly book value is now -69.05% below its all-time high of $79.60 million, reached on 01 March 2021.TOVX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Book Value Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.7% | -40.1% |
3 y3 years | +610.3% | -62.3% |
5 y5 years | +1357.2% | +937.9% |
TOVX Book Value High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -43.5% | +610.3% | -63.8% | at low |
5 y | 5 years | -43.5% | +610.3% | -69.0% | +385.3% |
alltime | all time | -43.5% | +340.2% | -69.0% | +246.8% |
Theriva Biologics Book Value History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $24.64 M(-4.9%) |
June 2024 | - | $25.90 M(-17.5%) |
Mar 2024 | - | $31.39 M(-15.1%) |
Dec 2023 | $36.96 M(-28.7%) | $36.96 M(-10.2%) |
Sept 2023 | - | $41.15 M(-8.6%) |
June 2023 | - | $45.02 M(-5.9%) |
Mar 2023 | - | $47.85 M(-7.7%) |
Dec 2022 | $51.83 M(-20.8%) | $51.83 M(-6.5%) |
Sept 2022 | - | $55.41 M(-10.1%) |
June 2022 | - | $61.67 M(-9.3%) |
Mar 2022 | - | $68.03 M(+4.0%) |
Dec 2021 | $65.41 M(-1002.9%) | - |
Dec 2021 | - | $65.41 M(-10.8%) |
Sept 2021 | - | $73.33 M(-4.1%) |
June 2021 | - | $76.50 M(-3.9%) |
Mar 2021 | - | $79.60 M(-1198.8%) |
Dec 2020 | -$7.24 M(+146.4%) | -$7.24 M(-16.1%) |
Sept 2020 | - | -$8.63 M(+16.5%) |
June 2020 | - | -$7.41 M(+42.1%) |
Mar 2020 | - | -$5.21 M(+77.3%) |
Dec 2019 | -$2.94 M(-126.0%) | -$2.94 M(-2822.2%) |
Sept 2019 | - | $108.00 K(-97.9%) |
June 2019 | - | $5.09 M(-39.4%) |
Mar 2019 | - | $8.40 M(-25.7%) |
Dec 2018 | $11.31 M(-855.9%) | $11.31 M(-402.9%) |
Sept 2018 | - | -$3.73 M(-42.5%) |
June 2018 | - | -$6.49 M(+103.6%) |
Mar 2018 | - | -$3.19 M(+113.0%) |
Dec 2017 | -$1.50 M(-138.9%) | -$1.50 M(-91.1%) |
Sept 2017 | - | -$16.78 M(-447.4%) |
June 2017 | - | $4.83 M(+88.0%) |
Mar 2017 | - | $2.57 M(-33.2%) |
Dec 2016 | $3.85 M(-76.0%) | $3.85 M(-185.9%) |
Sept 2016 | - | -$4.48 M(-295.1%) |
June 2016 | - | $2.29 M(-63.3%) |
Mar 2016 | - | $6.26 M(-61.0%) |
Dec 2015 | $16.05 M(+68.0%) | $16.05 M(-38.0%) |
Sept 2015 | - | $25.87 M(-289.4%) |
June 2015 | - | -$13.66 M(+740.7%) |
Mar 2015 | - | -$1.63 M(-117.0%) |
Dec 2014 | $9.56 M(-37.3%) | $9.56 M(+154.4%) |
Sept 2014 | - | $3.76 M(-53.4%) |
June 2014 | - | $8.06 M(-31.5%) |
Mar 2014 | - | $11.76 M(-22.8%) |
Dec 2013 | $15.23 M(+16.9%) | $15.23 M(+139.1%) |
Sept 2013 | - | $6.37 M(-32.2%) |
June 2013 | - | $9.40 M(-18.2%) |
Mar 2013 | - | $11.49 M(-11.8%) |
Dec 2012 | $13.03 M(+84.6%) | $13.03 M(+140.9%) |
Sept 2012 | - | $5.41 M(-21.0%) |
June 2012 | - | $6.85 M(-13.4%) |
Mar 2012 | - | $7.91 M(+12.0%) |
Dec 2011 | $7.06 M(+97.2%) | $7.06 M(-16.4%) |
Sept 2011 | - | $8.44 M(-7.5%) |
June 2011 | - | $9.12 M(+51.9%) |
Mar 2011 | - | $6.01 M(+67.8%) |
Dec 2010 | $3.58 M | $3.58 M(-15.6%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $4.24 M(+10.3%) |
June 2010 | - | $3.84 M(+38.6%) |
Mar 2010 | - | $2.77 M(-21.8%) |
Dec 2009 | $3.54 M(-47.6%) | $3.54 M(-23.4%) |
Sept 2009 | - | $4.63 M(-10.3%) |
June 2009 | - | $5.16 M(-12.7%) |
Mar 2009 | - | $5.91 M(-12.6%) |
Dec 2008 | $6.76 M(-43.4%) | $6.76 M(-10.2%) |
Sept 2008 | - | $7.53 M(-12.4%) |
June 2008 | - | $8.60 M(-9.7%) |
Mar 2008 | - | $9.52 M(-20.3%) |
Dec 2007 | $11.95 M(+1.3%) | $11.95 M(+58.0%) |
Sept 2007 | - | $7.56 M(-16.5%) |
June 2007 | - | $9.05 M(-13.4%) |
Mar 2007 | - | $10.45 M(-11.3%) |
Dec 2006 | $11.79 M(-1762.9%) | $11.79 M(<-9900.0%) |
Sept 2006 | - | -$3000.00(-106.0%) |
June 2006 | - | $49.70 K(-628.7%) |
Mar 2006 | - | -$9400.00(-99.9%) |
Dec 2005 | -$708.80 K(-95.4%) | - |
Mar 2003 | - | -$16.24 M(+5.6%) |
Dec 2002 | -$15.39 M(+69.3%) | -$15.39 M(+6.9%) |
Sept 2002 | - | -$14.39 M(+9.8%) |
June 2002 | - | -$13.11 M(+19.4%) |
Mar 2002 | - | -$10.98 M(+20.9%) |
Dec 2001 | -$9.09 M(+2096.4%) | -$9.09 M(+65.0%) |
Sept 2001 | - | -$5.51 M(+95.0%) |
June 2001 | - | -$2.82 M(+47.3%) |
Mar 2001 | - | -$1.92 M(+363.6%) |
Dec 2000 | -$413.70 K(-161.6%) | -$413.70 K(-40.4%) |
Sept 2000 | - | -$694.70 K(+245.3%) |
June 2000 | - | -$201.20 K(-109.1%) |
Mar 2000 | - | $2.21 M(+229.6%) |
Dec 1999 | $671.10 K(-4.1%) | $671.10 K(-121.0%) |
Sept 1999 | - | -$3.20 M(+88.2%) |
June 1999 | - | -$1.70 M(+240.0%) |
Mar 1999 | - | -$500.00 K(-171.4%) |
Dec 1998 | $700.00 K(-131.8%) | $700.00 K(-56.3%) |
Sept 1998 | - | $1.60 M(-66.7%) |
June 1998 | - | $4.80 M(-229.7%) |
Mar 1998 | - | -$3.70 M(+68.2%) |
Dec 1997 | -$2.20 M(-229.4%) | -$2.20 M(+37.5%) |
Sept 1997 | - | -$1.60 M(-1700.0%) |
June 1997 | - | $100.00 K(-95.0%) |
Mar 1997 | - | $2.00 M(+17.6%) |
Dec 1996 | $1.70 M(-5.6%) | $1.70 M(-56.4%) |
Sept 1996 | - | $3.90 M(-20.4%) |
June 1996 | - | $4.90 M(+145.0%) |
Mar 1996 | - | $2.00 M(+11.1%) |
Dec 1995 | $1.80 M(-400.0%) | $1.80 M(-40.0%) |
Sept 1995 | - | $3.00 M(-600.0%) |
Dec 1994 | -$600.00 K(-135.3%) | -$600.00 K(-113.3%) |
Mar 1994 | - | $4.50 M(+164.7%) |
Dec 1993 | $1.70 M | $1.70 M(-41.4%) |
Sept 1993 | - | $2.90 M(-31.0%) |
June 1993 | - | $4.20 M(+2.4%) |
Mar 1993 | - | $4.10 M |
FAQ
- What is Theriva Biologics annual book value?
- What is the all time high annual book value for Theriva Biologics?
- What is Theriva Biologics annual book value year-on-year change?
- What is Theriva Biologics quarterly book value?
- What is the all time high quarterly book value for Theriva Biologics?
- What is Theriva Biologics quarterly book value year-on-year change?
What is Theriva Biologics annual book value?
The current annual book value of TOVX is $36.96 M
What is the all time high annual book value for Theriva Biologics?
Theriva Biologics all-time high annual book value is $65.41 M
What is Theriva Biologics annual book value year-on-year change?
Over the past year, TOVX annual book value has changed by -$14.87 M (-28.68%)
What is Theriva Biologics quarterly book value?
The current quarterly book value of TOVX is $24.64 M
What is the all time high quarterly book value for Theriva Biologics?
Theriva Biologics all-time high quarterly book value is $79.60 M
What is Theriva Biologics quarterly book value year-on-year change?
Over the past year, TOVX quarterly book value has changed by -$16.52 M (-40.13%)